These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12623982)

  • 1. Contributions of 20-HETE to the antihypertensive effects of Tempol in Dahl salt-sensitive rats.
    Hoagland KM; Maier KG; Roman RJ
    Hypertension; 2003 Mar; 41(3 Pt 2):697-702. PubMed ID: 12623982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
    Bayorh MA; Mann G; Walton M; Eatman D
    Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive rats.
    Kobori H; Nishiyama A
    Biochem Biophys Res Commun; 2004 Mar; 315(3):746-50. PubMed ID: 14975764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TEMPOL enhances the antihypertensive effects of sodium nitrite by mechanisms facilitating nitrite-derived gastric nitric oxide formation.
    Amaral JH; Montenegro MF; Pinheiro LC; Ferreira GC; Barroso RP; Costa-Filho AJ; Tanus-Santos JE
    Free Radic Biol Med; 2013 Dec; 65():446-455. PubMed ID: 23892053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension.
    Elmarakby AA; Williams JM; Imig JD; Pollock JS; Pollock DM
    Vascul Pharmacol; 2007 Feb; 46(2):144-51. PubMed ID: 17112788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2alpha.
    Schnackenberg CG; Wilcox CS
    Hypertension; 1999 Jan; 33(1 Pt 2):424-8. PubMed ID: 9931141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic arterial pressure response to two weeks of Tempol therapy in SHR: involvement of NO, the RAS, and oxidative stress.
    Yanes L; Romero D; Iliescu R; Cucchiarelli VE; Fortepiani LA; Santacruz F; Bell W; Zhang H; Reckelhoff JF
    Am J Physiol Regul Integr Comp Physiol; 2005 Apr; 288(4):R903-8. PubMed ID: 15604302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats.
    Kawarazaki H; Ando K; Nagae A; Fujita M; Matsui H; Fujita T
    Nephrol Dial Transplant; 2010 Sep; 25(9):2879-89. PubMed ID: 20466668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced superoxide activity modulates renal function in NO-deficient hypertensive rats.
    Kopkan L; Majid DS
    Hypertension; 2006 Mar; 47(3):568-72. PubMed ID: 16401762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of 20-HETE formation promote salt-sensitive hypertension in rats.
    Hoagland KM; Flasch AK; Roman RJ
    Hypertension; 2003 Oct; 42(4):669-73. PubMed ID: 12874093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tempol, a superoxide dismutase-mimetic drug, prevents chronic ischemic renal injury in two-kidney, one-clip hypertensive rats.
    Nunes DV; Costa CA; De Bem GF; Cordeiro VS; Santos IB; Carvalho LC; Jordão AK; Cunha AC; Ferreira VF; Moura RS; Resende AC; Ognibene DT
    Clin Exp Hypertens; 2018; 40(8):721-729. PubMed ID: 29359965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive response to prolonged tempol in the spontaneously hypertensive rat.
    Welch WJ; Mendonca M; Blau J; Karber A; Dennehy K; Patel K; Lao YS; José PA; Wilcox CS
    Kidney Int; 2005 Jul; 68(1):179-87. PubMed ID: 15954907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tempol-nebivolol therapy potentiates hypotensive effect increasing NO bioavailability and signaling pathway.
    Bertera FM; Santa-Cruz DM; Balestrasse KB; Gorzalczany SB; Höcht C; Taira CA; Polizio AH
    Free Radic Res; 2014 Feb; 48(2):109-18. PubMed ID: 24074298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superoxide contributes to development of salt sensitivity and hypertension induced by nitric oxide deficiency.
    Kopkan L; Majid DS
    Hypertension; 2005 Oct; 46(4):1026-31. PubMed ID: 16103275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased renal medullary H2O2 leads to hypertension.
    Makino A; Skelton MM; Zou AP; Cowley AW
    Hypertension; 2003 Jul; 42(1):25-30. PubMed ID: 12782642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species.
    Jaimes EA; Zhou MS; Pearse DD; Puzis L; Raij L
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F385-92. PubMed ID: 18094033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic antioxidant therapy lowers blood pressure in adult but not in young Dahl salt hypertensive rats: the role of sympathetic nervous system.
    Vaněčková I; Vokurková M; Rauchová H; Dobešová Z; Pecháňová O; Kuneš J; Vorlíček J; Zicha J
    Acta Physiol (Oxf); 2013 Aug; 208(4):340-9. PubMed ID: 23480535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The altered balance between sympathetic nervous system and nitric oxide in salt hypertensive Dahl rats: ontogenetic and F2 hybrid studies.
    Dobesová Z; Kunes J; Zicha J
    J Hypertens; 2002 May; 20(5):945-55. PubMed ID: 12011656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress in Dahl salt-sensitive hypertension.
    Meng S; Cason GW; Gannon AW; Racusen LC; Manning RD
    Hypertension; 2003 Jun; 41(6):1346-52. PubMed ID: 12719439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathoexcitation by brain oxidative stress mediates arterial pressure elevation in salt-induced chronic kidney disease.
    Fujita M; Ando K; Kawarazaki H; Kawarasaki C; Muraoka K; Ohtsu H; Shimizu H; Fujita T
    Hypertension; 2012 Jan; 59(1):105-12. PubMed ID: 22083162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.